Constellation Brands
STZ
$146.47
-0.75%
Constellation Brands is the largest provider of alcoholic beverages in the US, with a dominant position in the high-margin Mexican import beer category through powerhouse brands like Modelo and Corona, which drive over 90% of revenue. The company is a clear market leader in its core beer segment, leveraging exclusive US import rights to create a formidable competitive moat, while strategically pruning its non-core wine and spirits assets. The current investor narrative is focused on the company's ability to sustain premium growth and margins in a potentially slowing consumer environment, as evidenced by recent stock volatility following earnings reports where strong results were overshadowed by future profit guidance that disappointed the market, highlighting the debate over its growth trajectory and valuation.…
STZ
Constellation Brands
$146.47
Related headlines
Investment Opinion: Should I buy STZ Today?
Rating: Hold. The core thesis is that STZ is a high-quality franchise facing a cyclical growth scare, currently trading at a valuation that largely reflects these near-term challenges, but lacking a clear near-term catalyst for a re-rating.
Supporting evidence includes the stock's discounted forward P/E of 11.42x, which is significantly below its trailing multiple and suggests lowered expectations. The company's robust net margin of 18.46% and strong ROE of 20.87% underscore its operational excellence. Furthermore, the tight 4.9% spread in analyst revenue estimates indicates a base of stability in the financial outlook, while the substantial $1.76 billion in TTM free cash flow provides a margin of safety.
The thesis would upgrade to a Buy if revenue growth returns to positive territory, confirming the decline as temporary, or if the forward P/E compresses further toward 10x, offering a deeper margin of safety. It would downgrade to a Sell if quarterly revenue declines accelerate beyond 10% YoY or if gross margins (currently 53.23%) show sustained deterioration. Relative to its own history and given its profitability profile, the stock appears fairly valued to slightly undervalued, but not compellingly cheap enough to overcome the clear negative momentum and growth concerns.
Sign up to view all
STZ 12-Month Price Forecast
STZ presents a classic conflict between deteriorating momentum and attractive fundamentals. The company's dominant market position and cash-generative business model are undeniable strengths, but they are currently overshadowed by worrying signs of top-line contraction. The forward P/E of 11.42x suggests the market is not ignoring these risks. The stance is neutral because the path of least resistance appears to be sideways consolidation until growth trends clarify. The stance would upgrade to bullish on evidence of revenue stabilization or a successful defense of market share. It would turn bearish if the next quarter confirms the sales decline is accelerating, validating the technical breakdown.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Constellation Brands's 12-month outlook, with a consensus price target around $190.41 and implied upside of +30.0% versus the current price.
Average Target
$190.41
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$117 - $190
Analyst target range
A limited cohort of 7 analysts provides coverage on the stock, with recent institutional ratings showing a mix of Buy, Hold, and Outperform actions, including an upgrade from Citigroup to Buy in March 2026, indicating some positive sentiment shifts. The average analyst revenue estimate for the upcoming period is $10.11 billion, with a range from $9.86 billion to $10.32 billion; the tight 4.9% spread between the low and high estimates suggests a relatively high degree of consensus and conviction among covering analysts regarding the company's near-term revenue trajectory, despite the stock's recent performance challenges.
Bulls vs Bears: STZ Investment Factors
The evidence currently tilts bearish, primarily due to the stock's severe technical breakdown and the concrete deceleration in revenue growth, which directly challenges the core investment thesis of sustained premium growth. The bull case rests on the company's undeniable competitive moat, strong cash generation, and what appears to be a valuation that has priced in significant pessimism. The single most important tension in the investment debate is whether the recent revenue decline is a temporary blip in a dominant franchise or the beginning of a structural slowdown in its core beer segment. The resolution of this tension, evidenced by future quarterly sales figures, will most decisively change the thesis.
Bullish
- Dominant Market Position & Moat: Constellation Brands holds exclusive US import rights for powerhouse Mexican beer brands Modelo and Corona, which drive over 90% of revenue. This creates a formidable competitive moat in the high-margin import beer category, providing pricing power and resilience.
- Strong Profitability & Cash Generation: The company maintains robust profitability with a trailing net margin of 18.46% and generated $1.76 billion in TTM free cash flow. This strong cash flow provides ample capacity to service its debt, fund its dividend (2.58% yield), and repurchase shares.
- Attractive Valuation Multiples: STZ trades at a forward P/E of 11.42x, a significant discount to its trailing P/E of 16.42x, implying the market has already priced in lowered near-term expectations. The current trailing P/E is also below its own historical range, suggesting relative undervaluation.
- Analyst Consensus on Revenue Trajectory: Covering analysts show high conviction with a tight 4.9% spread between low ($9.86B) and high ($10.32B) revenue estimates for the upcoming period, averaging $10.11 billion. This consensus suggests a stable outlook despite recent stock volatility.
Bearish
- Revenue Decline & Growth Deceleration: Recent quarterly revenue of $2.22 billion represents a 9.8% year-over-year decline, and revenue has sequentially fallen from $2.51 billion in Q1 2026. This clear deceleration, primarily in the core beer segment, raises concerns about the sustainability of its growth narrative.
- Technical Downtrend & Weak Momentum: The stock is in a pronounced downtrend, down 25.33% over the past year and trading at just 72.3% of its 52-week range. Recent momentum is decisively negative, with the stock down 13.17% over the past month, indicating a clear breakdown and lack of near-term support.
- High Financial Leverage: The company carries significant debt with a debt-to-equity ratio of 1.39. While strong cash flow mitigates this risk, the leverage amplifies financial risk if revenue and margin pressures persist, potentially constraining strategic flexibility.
- Disappointing Future Profit Guidance: Despite beating Q4 earnings estimates, the stock fell due to disappointing future profit guidance that missed Wall Street's expectations. This highlights the market's focus on forward growth trajectory, which currently appears challenged.
STZ Technical Analysis
The stock is in a pronounced downtrend, having declined 25.33% over the past year, and is currently trading at just 72.3% of its 52-week range, positioned much closer to its 52-week low of $126.45 than its high of $196.91, suggesting it is in a value-seeking zone but remains under significant selling pressure. Recent momentum is decisively negative and accelerating the longer-term decline, with the stock down 13.17% over the past month and 4.66% over the past three months, indicating a clear breakdown and lack of near-term support. Key technical support is firmly established at the 52-week low of $126.45, while resistance sits at the recent highs near $166.68; a sustained break below support would signal a continuation of the bearish trend, while the stock's low beta of 0.424 indicates it has been significantly less volatile than the broader market, which may offer some relative stability during this decline but also suggests it has lacked the momentum to participate in market rallies.
Beta
0.42
0.42x market volatility
Max Drawdown
-34.8%
Largest decline past year
52-Week Range
$126-$194
Price range past year
Annual Return
-24.1%
Cumulative gain past year
| Period | STZ Return | S&P 500 |
|---|---|---|
| 1m | -9.7% | +3.3% |
| 3m | -6.3% | +6.9% |
| 6m | +12.3% | +12.4% |
| 1y | -24.1% | +23.4% |
| ytd | +3.8% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
STZ Fundamental Analysis
Revenue growth has stalled and turned negative, with the most recent quarterly revenue of $2.22 billion representing a 9.8% year-over-year decline, and the multi-quarter trend shows revenue has sequentially fallen from $2.51 billion in Q1 2026, indicating a clear deceleration primarily within its core beer segment, which generated $2.01 billion in the last quarter. The company remains profitable with strong margins, posting net income of $502.8 million and a robust gross margin of 53.23% last quarter, though operating income of $692 million was down from prior quarters, reflecting some margin pressure amidst the sales decline. The balance sheet is leveraged with a debt-to-equity ratio of 1.39, but the company generates substantial cash, evidenced by trailing twelve-month free cash flow of $1.76 billion and a healthy return on equity of 20.87%, providing ample capacity to service debt, fund its dividend, and repurchase shares.
Quarterly Revenue
$2.2B
2025-11
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is STZ Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 16.42x and a forward PE of 11.42x; the significant discount of the forward multiple implies the market expects earnings growth or reflects lowered near-term expectations. Compared to sector averages, the trailing PE of 16.42x is likely at a discount to many consumer staple peers, though specific industry comps are not provided in the data; the valuation appears reasonable given the company's high net margin of 18.46% and strong cash generation. Historically, the current trailing PE of 16.42x is below the stock's own historical range seen in recent quarters, which has fluctuated between approximately 11.96x and 81.92x over the past few years, suggesting the stock is trading at a relatively low valuation relative to its own history, potentially pricing in the recent growth concerns.
PE
16.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -21x~6710x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks stem primarily from the company's leveraged balance sheet, with a debt-to-equity ratio of 1.39, which could pressure financial flexibility if interest rates remain elevated. More critically, revenue concentration risk is extreme, with over 90% of sales tied to Mexican import beers, making the company vulnerable to any shift in consumer preference, regulatory changes on imports, or competitive incursions into this niche. While strong cash flow ($1.76B TTM FCF) and profitability (18.46% net margin) provide a buffer, the recent 9.8% YoY revenue decline indicates these risks are materializing as operational headwinds.
Market & Competitive Risks are heightened by the stock's valuation compression risk. Despite trading at a seemingly reasonable forward P/E of 11.42x, the stock's 25.33% decline over the past year starkly underperforms the S&P 500's 25.19% gain, indicating severe negative sector rotation and a re-rating. The low beta of 0.424 confirms it has lacked participation in market rallies. Recent industry news highlights consolidation and slowing consumer demand, suggesting the entire alcoholic beverage sector may be facing a 'growth hangover,' which could limit STZ's multiple expansion potential regardless of company-specific execution.
Worst-Case Scenario involves a continuation of the current revenue decline coupled with margin compression, triggering a downward spiral where high leverage becomes burdensome, leading to dividend cuts or suspended buybacks. This could be exacerbated by a recessionary consumer environment. The realistic downside is significant; a retest and break below the 52-week low of $126.45 would represent a further 11% decline from the current price of ~$142.35. Given the stock's historical max drawdown of -34.75%, a severe bear case could see losses approaching 25-30% from current levels if growth concerns are confirmed as structural.
FAQ
The key risks are, in order of severity: 1) Growth Risk: The core beer segment, responsible for over 90% of revenue, is showing deceleration, with a 9.8% YoY sales decline last quarter. 2) Financial Risk: The company's leveraged balance sheet (debt-to-equity of 1.39) could become burdensome if profitability erodes. 3) Market Sentiment Risk: The stock has severely underperformed the market (50.5 percentage points worse over the past year), indicating negative sector rotation that may persist. 4) Guidance Risk: Future profit guidance has already disappointed the market once, creating high sensitivity to management's forward-looking statements.
The 12-month forecast is a range-bound outlook with a neutral bias. The base case (60% probability) sees the stock trading between $145 and $165 as growth stabilizes near analyst consensus estimates. The bull case (25% probability), targeting $175 to $196, requires a clear return to revenue growth. The bear case (15% probability), targeting $126 to $140, involves a continuation of the sales decline. The most likely scenario is the base case, predicated on the assumption that STZ's powerful brands and cash flows prevent a further derating, but that growth concerns limit significant multiple expansion in the near term.
STZ appears fairly valued to slightly undervalued based on its fundamentals. Its forward P/E of 11.42x represents a significant discount to its trailing P/E of 16.42x, indicating the market has already priced in lower near-term earnings growth. Compared to its own historical P/E range, which has been as high as 81.92x, the current multiple is at the low end. The valuation implies the market expects stagnation or very low growth, questioning the sustainability of its premium margins. Given its high profitability (18.46% net margin), the stock is not cheap for no reason, but the valuation does offer a margin of safety if the business stabilizes.
STZ is a conditional buy for a specific investor profile. For a value or income-focused investor with a multi-year horizon, the current price offers a compelling entry point into a dominant franchise with a 2.58% yield, trading at a forward P/E of 11.42x. However, it is not a good buy for growth investors or those seeking near-term capital appreciation, given the clear revenue deceleration (-9.8% YoY) and severe technical downtrend (-25.33% over the past year). The key condition for it being a 'good buy' is a belief that the company's brand moat will allow it to stabilize and eventually return to modest growth.
STZ is far more suitable for a long-term investment horizon of 3-5 years rather than short-term trading. Its low beta of 0.424 means it lacks the volatility typically desired for short-term trades, and the near-term catalyst (a return to growth) is uncertain. For the long-term investor, the thesis is that the company's durable competitive advantages and strong cash flows will ultimately allow it to navigate the current slowdown, and the current valuation provides an attractive entry point to collect a growing dividend. A minimum holding period of 18-24 months is suggested to allow for the operational story to play out.